Use of Cyclophosphamide, Vincristine, Prednisolone and Vinblastine for the Treatment of Large Cell Lymphoma in Cats
Journal of Veterinary Internal Medicine · 2025-03-01 · 39 (2)
DOI: 10.1111/jvim.70066 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, published online on 2025-03-01. Written by Lee Pui Yung Anna and 3 co-authors. Institution: Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong. Major MEDLINE topics: Cat Diseases, Antineoplastic Combined Chemotherapy Protocols. Cited 4 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: City University of Hong Kong.
Abstract (original language)
Background
The standard chemotherapy treatment for large-cell lymphoma in cats is CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) or COP (cyclophosphamide, vincristine, and prednisolone) chemotherapy protocols. Substituting vinblastine for vincristine might have similar efficacy, with lower severity of gastrointestinal adverse events. Hypothesis/Objectives To evaluate whether the addition of vinblastine to a low-dose vincristine COP protocol could reduce the frequency and severity of adverse gastrointestinal effects while maintaining or increasing efficacy. Animals Medical records of 41 cats with large-cell lymphoma treated with the modified COVP protocol at one veterinary referral institution.
Methods
Retrospective case series study. All relevant clinical data were retrospectively collected. Median progression-free survival, disease-free interval, and survival time were calculated using the Kaplan–Meier Method. Differences between groups were analyzed using the log-rank test, and adverse events were graded using VCOG-CTCAE v2.
Results
Progression-free survival was 264 days (range, 6–1486 days), the disease-free interval was 812 days (range, 39–1486 days) and the median survival time for all cats was 412 days (range, 7–1772 days). Complete response was achieved in 59% of the cases, and partial response was observed in 17%. Cats that achieved CR lived significantly longer, 838 days (range, 81–1772 days) versus 143 days (range, 10–798 days; p = 0.0018). The COVP protocol was generally well tolerated, and the most common adverse effects were mild signs of gastrointestinal disease and hematological abnormalities that did not require a pause in treatment. Grade-1 vomiting was the most common (24%), followed by grade-2 (22%) and grade-1 reduced appetite (20%).
Conclusion
Cats with lymphoma treated with COVP seem to achieve acceptable survival and response rates compared to traditional chemotherapy protocols.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
- Department of Veterinary Clinic and Surgery, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Infectious Diseases and Public Health, Jockey Club of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
- CityU Veterinary Medical Centre, Lai Chi Kok, Hong Kong.
- Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
Funding
- City University of Hong Kong
Cite
APA
Pui Yung Anna, L., Horta, R., Sze, C. N., & Giuliano, A. (2025). Use of Cyclophosphamide, Vincristine, Prednisolone and Vinblastine for the Treatment of Large Cell Lymphoma in Cats. Journal of Veterinary Internal Medicine, 39(2). https://doi.org/10.1111/jvim.70066
Vancouver
Pui Yung Anna L, Horta R, Sze CN, Giuliano A. Use of Cyclophosphamide, Vincristine, Prednisolone and Vinblastine for the Treatment of Large Cell Lymphoma in Cats. Journal of Veterinary Internal Medicine. 2025;39(2). doi:10.1111/jvim.70066
BibTeX
@article{PuiYungAnna2025,
author = {Pui Yung Anna, Lee and Horta, Rodrigo and Sze, Cheryl Nathalie and Giuliano, Antonio},
title = {Use of Cyclophosphamide, Vincristine, Prednisolone and Vinblastine for the Treatment of Large Cell Lymphoma in Cats},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
volume = {39},
number = {2},
doi = {10.1111/jvim.70066}
}
EUVIMED